Harnessing NK Cells for Cancer Treatment-Reference-Cited by-同舟云学术

Harnessing NK Cells for Cancer Treatment

Published:2019-12-06 Issue: Volume:10 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Minetto Paola,Guolo Fabio,Pesce Silvia,Greppi Marco,Obino Valentina,Ferretti Elisa,Sivori Simona,Genova Carlo,Lemoli Roberto Massimo,Marcenaro Emanuela

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference105 articles.

1. Melanoma drug wins US approval;Ledford;Nature,2011

2. Novel cancer immunotherapy agents with survival benefit: recent successes and next steps;Sharma;Nat Rev Cancer,2011

3. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer;Topalian;N Engl J Med,2012

4. The blockade of immune checkpoints in cancer immunotherapy;Pardoll;Nat Rev Cancer,2012

5. Immunological agents used in cancer treatment;Simsek;Eurasian J Med,2019

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The microtubule targeting agent ST-401 triggers cell death in interphase and prevents the formation of polyploid giant cancer cells;Journal of Translational Medicine;2024-05-10

2. Impact of antibody architecture and paratope valency on effector functions of bispecific NKp30 x EGFR natural killer cell engagers;mAbs;2024-02-19

3. A promising natural killer cell-based model and a nomogram for the prognostic prediction of clear-cell renal cell carcinoma;European Journal of Medical Research;2024-01-24

4. Prognosis and therapy in thyroid cancer by gene signatures related to natural killer cells;The Journal of Gene Medicine;2024-01

5. Immunomodulatory hydrogels;Multiscale Cell-Biomaterials Interplay in Musculoskeletal Tissue Engineering and Regenerative Medicine;2024